Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carotid Artery, Internal, Dissection | 1 | 2022 | 40 | 0.800 |
Why?
|
| Vertebral Artery Dissection | 1 | 2022 | 48 | 0.790 |
Why?
|
| Discitis | 1 | 2022 | 45 | 0.760 |
Why?
|
| Osteomyelitis | 1 | 2022 | 407 | 0.590 |
Why?
|
| Radiology | 2 | 2021 | 2114 | 0.560 |
Why?
|
| Physicians | 1 | 2021 | 4583 | 0.210 |
Why?
|
| Internship and Residency | 1 | 2021 | 5879 | 0.180 |
Why?
|
| Edema | 1 | 2022 | 765 | 0.150 |
Why?
|
| Arteries | 1 | 2022 | 1121 | 0.140 |
Why?
|
| Schools, Medical | 1 | 2021 | 877 | 0.120 |
Why?
|
| Thyroidectomy | 3 | 2010 | 908 | 0.110 |
Why?
|
| Spine | 1 | 2021 | 1128 | 0.110 |
Why?
|
| Faculty, Medical | 1 | 2021 | 1205 | 0.100 |
Why?
|
| Lumbar Vertebrae | 1 | 2022 | 1876 | 0.100 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2016 | 926 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 3821 | 0.080 |
Why?
|
| Carcinoma, Medullary | 1 | 2009 | 115 | 0.080 |
Why?
|
| Thyroid Diseases | 2 | 2008 | 386 | 0.070 |
Why?
|
| Peer Review | 1 | 2009 | 217 | 0.070 |
Why?
|
| Thyrotropin | 1 | 2010 | 834 | 0.070 |
Why?
|
| Thyroxine | 1 | 2010 | 666 | 0.070 |
Why?
|
| Thyroid Neoplasms | 2 | 2010 | 2331 | 0.060 |
Why?
|
| Endocrine System Diseases | 1 | 2007 | 249 | 0.060 |
Why?
|
| Hospital Costs | 2 | 2008 | 947 | 0.060 |
Why?
|
| Specialties, Surgical | 1 | 2007 | 389 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 7873 | 0.050 |
Why?
|
| Publishing | 1 | 2009 | 832 | 0.050 |
Why?
|
| Fibrinolysis | 1 | 2002 | 332 | 0.050 |
Why?
|
| Pandemics | 1 | 2021 | 8663 | 0.050 |
Why?
|
| Humans | 13 | 2022 | 761098 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2016 | 9278 | 0.040 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2009 | 2025 | 0.040 |
Why?
|
| General Surgery | 1 | 2009 | 1692 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 36418 | 0.040 |
Why?
|
| Length of Stay | 2 | 2008 | 6420 | 0.040 |
Why?
|
| Hospital Mortality | 2 | 2008 | 5296 | 0.030 |
Why?
|
| United States | 4 | 2021 | 72337 | 0.030 |
Why?
|
| Back Pain | 1 | 2021 | 545 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2002 | 1443 | 0.030 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2002 | 1162 | 0.030 |
Why?
|
| Inpatients | 1 | 2007 | 2545 | 0.030 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2016 | 190 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2007 | 2372 | 0.030 |
Why?
|
| Mastectomy, Segmental | 1 | 2016 | 955 | 0.020 |
Why?
|
| Hormone Replacement Therapy | 1 | 2016 | 751 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 20981 | 0.020 |
Why?
|
| Decision Trees | 1 | 2010 | 505 | 0.020 |
Why?
|
| Journal Impact Factor | 1 | 2009 | 153 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 11732 | 0.020 |
Why?
|
| Calcitonin | 1 | 2009 | 329 | 0.020 |
Why?
|
| Quality Control | 1 | 2009 | 834 | 0.020 |
Why?
|
| Markov Chains | 1 | 2010 | 965 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 2010 | 1030 | 0.020 |
Why?
|
| Peer Review, Research | 1 | 2009 | 339 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 14676 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15308 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2010 | 1664 | 0.010 |
Why?
|
| Boston | 1 | 2016 | 9324 | 0.010 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2010 | 1723 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 2002 | 213 | 0.010 |
Why?
|
| Apolipoprotein E3 | 1 | 2002 | 107 | 0.010 |
Why?
|
| Age Distribution | 1 | 2008 | 2873 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 58946 | 0.010 |
Why?
|
| Apolipoprotein E2 | 1 | 2002 | 135 | 0.010 |
Why?
|
| Workload | 1 | 2007 | 844 | 0.010 |
Why?
|
| Needs Assessment | 1 | 2007 | 1139 | 0.010 |
Why?
|
| Employment | 1 | 2007 | 1114 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 6507 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2010 | 2000 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 2002 | 432 | 0.010 |
Why?
|
| Fellowships and Scholarships | 1 | 2007 | 1116 | 0.010 |
Why?
|
| Forecasting | 1 | 2007 | 2928 | 0.010 |
Why?
|
| Periodicals as Topic | 1 | 2009 | 1463 | 0.010 |
Why?
|
| Apolipoprotein E4 | 1 | 2002 | 709 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2002 | 1696 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 5494 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2008 | 26068 | 0.010 |
Why?
|
| Adult | 4 | 2016 | 221083 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39121 | 0.010 |
Why?
|
| Female | 5 | 2016 | 392458 | 0.010 |
Why?
|
| Aged | 3 | 2016 | 169266 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2016 | 80673 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2009 | 6585 | 0.010 |
Why?
|
| Male | 4 | 2010 | 360675 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 74219 | 0.010 |
Why?
|
| Middle Aged | 2 | 2016 | 220835 | 0.000 |
Why?
|
| Prognosis | 1 | 2009 | 29672 | 0.000 |
Why?
|
| Genotype | 1 | 2002 | 12983 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 20600 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2007 | 15634 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2008 | 64670 | 0.000 |
Why?
|
| Time Factors | 1 | 2002 | 39953 | 0.000 |
Why?
|
| Adolescent | 1 | 2007 | 88271 | 0.000 |
Why?
|
Concepts
(93)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_